Xylem’s (XYL) “Outperform” Rating Reiterated at Oppenheimer
Oppenheimer reiterated their outperform rating on shares of Xylem (NYSE:XYL – Free Report) in a research note issued to investors on Wednesday morning,Benzinga reports. They currently have a $150.00 price objective on the industrial products company’s stock, down from their previous price objective of $158.00. Several other equities analysts also recently commented on the company. […]
Park Aerospace’s (PKE) Market Outperform Rating Reiterated at Citizens Jmp
Citizens Jmp reiterated their market outperform rating on shares of Park Aerospace (NYSE:PKE – Free Report) in a research note released on Friday morning,Benzinga reports. The firm currently has a $42.00 price objective on the semiconductor company’s stock. Other analysts have also issued reports about the stock. Weiss Ratings lowered shares of Park Aerospace from […]
Rocket Pharmaceuticals’ (RCKT) “Outperform” Rating Reiterated at Wedbush
Wedbush restated their outperform rating on shares of Rocket Pharmaceuticals (NASDAQ:RCKT – Free Report) in a research note released on Wednesday,Benzinga reports. Several other equities analysts also recently commented on RCKT. Jefferies Financial Group restated a “hold” rating and issued a $2.95 price target on shares of Rocket Pharmaceuticals in a research note on Wednesday. […]
Timken’s (TKR) Outperform Rating Reiterated at Oppenheimer
Oppenheimer reaffirmed their outperform rating on shares of Timken (NYSE:TKR – Free Report) in a research report report published on Thursday,Benzinga reports. Oppenheimer currently has a $150.00 price objective on the industrial products company’s stock. A number of other equities research analysts also recently weighed in on the company. Weiss Ratings raised Timken from a […]
last updated on 17 Oct 08:29